Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy
Clinical trial NCT05909761 · RECRUITING
Trial details
- NCT number
- NCT05909761
- Sponsor
- Amgen
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-04-15
- Primary completion
- 2032-10-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.